Lower risk Medical device recall · FDA · Published March 24, 2026

Remel Yeastone Broth Recall: Incorrect Lab Results Risk Delayed Treatment

Remel recalls Yeastone Broth (11ML, 10/BOX YY3462) due to potential incorrect lab results causing delayed antifungal treatment. Affected lots include 321046, 329835, 330316, 327069, 330317, 336325, 338314, 341161, 303851, 311723.

Plain-English summary generated from official FDA data by GovInfoNow · Published by Carlos Caban · How we make summaries

🇺🇸 FDA recall #Z-1806-2026Medical device Remel ›

Lower-risk recall

Products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result.

Take action

Contact the company

Recalling firmRemel, Inc12076 Santa Fe Trail Dr · Lenexa, KS 66215-3519

✎ GovInfoNow plain-language explainer

Remel is recalling Yeastone Broth (11ML, 10/BOX YY3462) because it may give incorrect lab results during quality control. This could lead to delayed treatment or needing a different antifungal drug if the lab ignores the test results. Read more at govinfonow.com/recall/49630-remel-yeastone-broth-recall-incorrect-lab-results-risk-delayed-treatment.

Source Summary by GovInfoNow · govinfonow.com/recall/49630-remel-yeastone-broth-recall-incorrect-lab-results-risk-delayed-treatment · Updated August 17, 2026 · FDA enforcement record: FDA #Z-1806-2026

Cite this page

“Remel Yeastone Broth Recall: Incorrect Lab Results Risk Delayed Treatment.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/49630-remel-yeastone-broth-recall-incorrect-lab-results-risk-delayed-treatment. Based on FDA recall #Z-1806-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1806-2026%22&limit=1).

The FDA announced on March 24, 2026, that Remel, Inc. is recalling Yeastone Broth because products may report incorrect AST results during quality control. This error can lead to delayed responses or the need to change antifungal agents if laboratory staff ignore the test result.

How to tell if you have it

Brand: Remel
Product: Yeastone Broth, 11ML, 10/BOX YY3462
UDI-DI: 848838018817
Lot codes: 321046, 329835, 330316, 327069, 330317, 336325, 338314, 341161, 303851, 311723
Units affected: 2819

The hazard

According to the FDA, Yeastone Broth products may report incorrect AST results during quality control. Health consequences may include delayed response or the need to change to another antifungal agent if laboratory ignores Quality Control test result.

Context

GovInfoNow's records show Remel, Inc has 22 other recalls on record since 2017-11-02. Other recent recalls of similar products include Remel GC Agar Base Recall (2026-06-03), Remel Campy CVA Medium 100/PK recall (2026-02-05), and Remel Lab Culture Media Recall (2025-11-12). Other recent recalls of similar products include Remel Oxoid Agglutinating Sera Recall (2026-03-25), Copan Italia DTT Liquid Reagent Recall (2025-10-29), and Oxoid Listeria Kits May Give Incorrect Results - Recall (2026-03-03).

How to tell if you have this one

Check the lot numbers on the packaging: 321046, 329835, 330316, 327069, 330317, 336325, 338314, 341161, 303851, 311723. The product is labeled as Yeastone Broth, 11ML, 10/BOX YY3462.

Brand
Remel
Category
Medical device

Based on the official FDA remedy

What to do — step by step

Check Product Lot Numbers
Look for lot numbers 321046, 329835, 330316, 327069, 330317, 336325, 338314, 341161, 303851, or 311723 on the packaging.

Where it went and when

Where it was distributed

Distributed nationwide, and outside the U.S.

FDA distribution: “Worldwide distribution - US Nationwide and the countries of Canada, Vietnam, France, Argentina, Qatar, New Zealand, Uruguay, Turkey, Netherlands, Singapore.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide, and outside the U.S.

Recall timeline

FDA published this recall 29 days after the firm started it.

Mar 24, 2026Firm started the recall
Apr 10, 2026FDA classified it Class II
Apr 22, 2026Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

From the GovInfoNow team · based on the FDA notice · How we make summaries

Is there a risk of serious injury from this product?

The recall is for potential lab errors, not physical injury risks. The hazard is low risk as it relates to test accuracy, not direct harm.

Similar recalls

Latest medical device recalls

Keep exploring

More Remel recalls

Link to this recall

<a href="https://govinfonow.com/recall/49630-remel-yeastone-broth-recall-incorrect-lab-results-risk-delayed-treatment">Remel Yeastone Broth Recall: Incorrect Lab Results Risk Delayed Treatment (GovInfoNow)</a>

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

Official source: FDA Recall #Z-1806-2026 (March 24, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1806-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.